| scholarly article | Q13442814 |
| P50 | author | Markus Büchler | Q89169 |
| Sebastian Schölch | Q41578801 | ||
| Christoph Reissfelder | Q86480797 | ||
| P2093 | author name string | M Koch | |
| C Kahlert | |||
| J Weitz | |||
| U Bork | |||
| N N Rahbari | |||
| P2860 | cites work | Significance of Circulating Tumor Cells Detected by the CellSearch System in Patients with Metastatic Breast Colorectal and Prostate Cancer | Q21296854 |
| Tumor cells circulate in the peripheral blood of all major carcinomas but not in healthy subjects or patients with nonmalignant diseases | Q28289395 | ||
| Circulating tumor cells, disease progression, and survival in metastatic breast cancer | Q29619276 | ||
| Isolation and characterization of circulating tumor cells in patients with metastatic colorectal cancer | Q33255975 | ||
| Adjuvant therapy after resection of colorectal liver metastases: the predictive value of the MSKCC clinical risk score in the era of modern chemotherapy | Q33558347 | ||
| Adjuvant chemotherapy for stage II colon cancer with poor prognostic features | Q34631210 | ||
| Molecular detection of persistent postoperative circulating tumour cells in stages II and III colon cancer patients via multiple blood sampling: prognostic significance of detection for early relapse | Q34745814 | ||
| Relationship of circulating tumor cells to tumor response, progression-free survival, and overall survival in patients with metastatic colorectal cancer | Q34790678 | ||
| NCCN Clinical Practice Guidelines in Oncology: colon cancer | Q35002984 | ||
| Circulating tumor cell count is a prognostic factor in metastatic colorectal cancer patients receiving first-line chemotherapy plus bevacizumab: a Spanish Cooperative Group for the Treatment of Digestive Tumors study. | Q36102824 | ||
| Meta-analysis shows that detection of circulating tumor cells indicates poor prognosis in patients with colorectal cancer | Q37681109 | ||
| The clinical significance of circulating tumor cells in non-metastatic colorectal cancer--a review | Q37842910 | ||
| Molecular detection of tumor cells in regional lymph nodes is associated with disease recurrence and poor survival in node-negative colorectal cancer: a systematic review and meta-analysis | Q37962293 | ||
| Circulating tumor cells in colorectal cancer patients. | Q38078600 | ||
| Colorectal carcinomas in 2013: the search for powerful prognostic markers is still on the go! | Q38216172 | ||
| Immune escape and survival mechanisms in circulating tumor cells of colorectal cancer | Q39238008 | ||
| Clinical significance of cytokeratin 20-positive circulating tumor cells detected by a refined immunomagnetic enrichment assay in colorectal cancer patients. | Q39888323 | ||
| Prognostic significance of circulating tumor cells in patients with metastatic colorectal cancer | Q46090380 | ||
| Circulating tumour cells in non-metastatic breast cancer: a prospective study | Q47652073 | ||
| Circulating tumor cells in patients with colorectal liver metastasis predict impaired survival | Q47914559 | ||
| Role of circulating tumour cells in predicting recurrence after excision of primary colorectal carcinoma | Q48650456 | ||
| Reporting recommendations for tumor marker prognostic studies (REMARK). | Q53268902 | ||
| Persistent presence of postoperative circulating tumor cells is a poor prognostic factor for patients with stage I-III colorectal cancer after curative resection. | Q53477288 | ||
| Clinical significance of circulating tumor cells, including cancer stem-like cells, in peripheral blood for recurrence and prognosis in patients with Dukes' stage B and C colorectal cancer. | Q54382043 | ||
| Detection of carcinoembryonic antigen messenger RNA-expressing cells in peripheral blood 7 days after curative surgery is a novel prognostic factor in colorectal cancer. | Q54564480 | ||
| Identification of early-stage colorectal cancer patients at risk of relapse post-resection by immunobead reverse transcription-PCR analysis of peritoneal lavage fluid for malignant cells. | Q54621338 | ||
| Usefulness and clinical significance of quantitative real-time RT-PCR to detect isolated tumor cells in the peripheral blood and tumor drainage blood of patients with colorectal cancer. | Q54624184 | ||
| Colorectal cancer | Q55924124 | ||
| Reduced Risk of Colorectal Cancer Up to 10 Years After Screening, Surveillance, or Diagnostic Colonoscopy | Q57191776 | ||
| Primary colon cancer: ESMO Clinical Practice Guidelines for diagnosis, adjuvant treatment and follow-up | Q57758169 | ||
| Circulating tumor cells in solid tumor in metastatic and localized stages | Q58371710 | ||
| Quantitative detection of CEA expressing free tumor cells in the peripheral blood of colorectal cancer patients during surgery with real-time RT-PCR on a LightCycler | Q74300556 | ||
| Multiple molecular markers as predictors of colorectal cancer in patients with normal perioperative serum carcinoembryonic antigen levels | Q80092353 | ||
| Colorectal cancer | Q81244694 | ||
| Prognostic impact of hematogenous tumor cell dissemination in patients with stage II colorectal cancer | Q82316464 | ||
| Compartmental differences of circulating tumor cells in colorectal cancer | Q83199388 | ||
| Low number of detectable circulating tumor cells in non-metastatic colon cancer | Q83541089 | ||
| Validation of prognostic scoring systems for patients undergoing resection of colorectal cancer liver metastases | Q84422732 | ||
| P275 | copyright license | Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International | Q42553662 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 8 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | colorectal carcinoma | Q25493920 |
| colorectal cancer | Q188874 | ||
| P304 | page(s) | 1306-1313 | |
| P577 | publication date | 2015-03-31 | |
| P1433 | published in | British Journal of Cancer | Q326309 |
| P1476 | title | Circulating tumour cells and outcome in non-metastatic colorectal cancer: a prospective study | |
| P478 | volume | 112 |
| Q92983460 | Analysis of colorectal cancer-related mutations by liquid biopsy: Utility of circulating cell-free DNA and circulating tumor cells |
| Q92539975 | Analytical validation of the CellMax platform for early detection of cancer by enumeration of rare circulating tumor cells |
| Q55692870 | Cancer Diagnosis Using a Liquid Biopsy: Challenges and Expectations. |
| Q39128280 | Cancer Moonshot Connecting International Liquid Biopsy Efforts Through Academic Partnership |
| Q36796137 | Circulating Tumor Cell Count Correlates with Colorectal Neoplasm Progression and Is a Prognostic Marker for Distant Metastasis in Non-Metastatic Patients |
| Q28067582 | Circulating Tumor Cell and Cell-free Circulating Tumor DNA in Lung Cancer |
| Q30355079 | Circulating Tumor Cells Versus Circulating Tumor DNA in Colorectal Cancer: Pros and Cons. |
| Q92542029 | Circulating Tumor Cells in Gastrointestinal Cancers: Current Status and Future Perspectives |
| Q92594244 | Circulating Tumour Cells, Circulating Tumour DNA and Circulating Tumour miRNA in Blood Assays in the Different Steps of Colorectal Cancer Management, a Review of the Evidence in 2019 |
| Q28066285 | Circulating and disseminated tumor cells: diagnostic tools and therapeutic targets in motion |
| Q41353471 | Circulating tumor cells exhibit stem cell characteristics in an orthotopic mouse model of colorectal cancer |
| Q26752116 | Circulating tumor cells in germ cell tumors: are those biomarkers of real prognostic value? A review |
| Q39151285 | Circulating tumor cells: clinical validity and utility |
| Q37566054 | Circulating tumor microemboli (CTM) and vimentin+ circulating tumor cells (CTCs) detected by a size-based platform predict worse prognosis in advanced colorectal cancer patients during chemotherapy |
| Q53755908 | Classifying circulating tumor cells to monitor cancer progression. |
| Q93073728 | Clinical Potential of Circulating Tumor Cells in Colorectal Cancer: A Prospective Study |
| Q38743200 | Clinical and biological significance of circulating tumor cells in cancer |
| Q41547611 | Clinical and biological significance of circulating tumor cells, circulating tumor DNA, and exosomes as biomarkers in colorectal cancer |
| Q50284929 | Clinical significance of peripheral circulating tumor cell counts in colorectal polyps and non-metastatic colorectal cancer |
| Q38375864 | Comparative Analysis of Tumor Cell Dissemination to the Sentinel Lymph Nodes and to the Bone Marrow in Patients With Nonmetastasized Colon Cancer: A Prospective Multicenter Study |
| Q37112963 | Comparison between Three Promising ß-emitting Radionuclides, (67)Cu, (47)Sc and (161)Tb, with Emphasis on Doses Delivered to Minimal Residual Disease |
| Q30234454 | Current approaches for avoiding the limitations of circulating tumor cells detection methods-implications for diagnosis and treatment of patients with solid tumors |
| Q50085047 | Current progress in research of circulating tumor cells |
| Q36322381 | Detection and Clinical Significance of Circulating Tumor Cells in Colorectal Cancer--20 Years of Progress. |
| Q92214841 | Detection of circulating tumor cells in colorectal cancer patients using the GILUPI CellCollector: results from a prospective, single-center study |
| Q36249373 | Detection of circulating tumor cells with CK20 RT-PCR is an independent negative prognostic marker in colon cancer patients - a prospective study |
| Q92237216 | Distribution of circulating tumor cell phenotype in early cervical cancer |
| Q64080755 | EVALUATING MMP-2 AND TGFß-RI EXPRESSION IN CIRCULATING TUMOR CELLS OF PANCREATIC CANCER PATIENTS AND THEIR CORRELATION WITH CLINICAL EVOLUTION |
| Q64262763 | Effect of exercise on colorectal cancer prevention and treatment |
| Q57454841 | Effects of exercise on circulating tumor cells among patients with resected stage I-III colon cancer |
| Q57286156 | Elevated circulating tumor cells and squamous cell carcinoma antigen levels predict poor survival for patients with locally advanced cervical cancer treated with radiotherapy |
| Q89860577 | Exosomal Non Coding RNA in LIQUID Biopsies as a Promising Biomarker for Colorectal Cancer |
| Q98177704 | From Cancer to Immune-Mediated Diseases and Tolerance Induction: Lessons Learned From Immune Oncology and Classical Anti-cancer Treatment |
| Q55361729 | Identifying patients with an unfavorable prognosis in early stages of colorectal carcinoma. |
| Q99570754 | Isolation and Enumeration of CTC in Colorectal Cancer Patients: Introduction of a Novel Cell Imaging Approach and Comparison to Cellular and Molecular Detection Techniques |
| Q51819604 | Isolation of Circulating Tumor Cells in an Orthotopic Mouse Model of Colorectal Cancer. |
| Q37708941 | LDB1 overexpression is a negative prognostic factor in colorectal cancer |
| Q49740946 | Liquid Biopsy in Clinical Management of Breast, Lung, and Colorectal Cancer |
| Q47372761 | Liquid biopsies in gastrointestinal malignancies: when is the big day? |
| Q33681010 | Meta-analysis Reveals the Prognostic Value of Circulating Tumour Cells Detected in the Peripheral Blood in Patients with Non-Metastatic Colorectal Cancer |
| Q51156242 | Microfluidic enrichment of circulating tumor cells in patients with clinically localized prostate cancer. |
| Q30249616 | Optimizing adjuvant therapy and survivorship care of stage III colon cancer. |
| Q91651645 | Perspectives of the Application of Liquid Biopsy in Colorectal Cancer |
| Q97519508 | Potential theranostics of circulating tumor cells and tumor-derived exosomes application in colorectal cancer |
| Q47106593 | Prognostic and clinicopathological significance of circulating tumor cells detected by RT-PCR in non-metastatic colorectal cancer: a meta-analysis and systematic review |
| Q90714242 | Prognostic significance of circulating tumor cells (CTCs) in Egyptian non-metastatic colorectal cancer patients: A comparative study for four different techniques of detection (Flowcytometry, CellSearch, Quantitative Real-time PCR and Cytomorphology |
| Q33913995 | Prognostic value of circulating endothelial cells in metastatic colorectal cancer |
| Q41120070 | Prospective assessment of the prognostic value of circulating tumor cells and their clusters in patients with advanced-stage breast cancer |
| Q28070120 | Recent advances in the biology of human circulating tumour cells and metastasis |
| Q41831515 | Serum CA19-9 as a marker of circulating tumor cells in first reflux blood of colorectal cancer patients |
| Q90344722 | Single Cell Transcriptome in Colorectal Cancer-Current Updates on Its Application in Metastasis, Chemoresistance and the Roles of Circulating Tumor Cells |
| Q64229129 | The Developing Story of Predictive Biomarkers in Colorectal Cancer |
| Q55280545 | The clinical value of circulating tumour cells (CTCs) in patients undergoing pulmonary metastasectomy for metastatic colorectal cancer. |
| Q41709112 | The prognostic and diagnostic value of circulating tumor cells in bladder cancer and upper tract urothelial carcinoma: a meta-analysis of 30 published studies |
Search more.